Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain
ether and amide functionality at the 1-position are useful as immune
response modifiers. The compounds and compositions of the invention can
induce the biosynthesis of various cytokines and are useful in the
treatment of a variety of conditions including viral diseases and
neoplastic diseases.